Melanosomes as Antigen-Presenting Decoys in Melanoma Immune Evasion

References

[1] Y. Chemla, O. Itzhaki, S. Melamed, et al., “HLA Export by Melanoma Cells Decoys Cytotoxic T Cells to Promote Immune Evasion,” Cell 189, no. 1 (2026): 233–251.e29.

[2] M. S. Carlino, J. Larkin, and G. V. Long, “Immune Checkpoint Inhibitors in Melanoma,” The Lancet 398, no. 10304 (2021): 1002–1014.

[3] B. M. Robertson, M. E. Fane, A. T. Weeraratna, et al., “Determinants of Resistance and Response to Melanoma Therapy,” Nature Cancer 5, no. 7 (2024): 964–982.

[4] S. Dror, L. Sander, H. Schwartz, et al., “Melanoma miRNA Trafficking Controls Tumour Primary Niche Formation,” Nature Cell Biology 18, no. 9 (2016): 1006–1017.

[5] R. Parikh, S. Parikh, and D. Berzin, “Recycled Melanoma-Secreted Melanosomes Regulate Tumor-Associated Macrophage Diversification,” The EMBO Journal 43, no. 17 (2024): 3553.

[6] H. Peinado, M. Alečković, and S. Lavotshkin, “Melanoma Exosomes Educate Bone Marrow Progenitor Cells Toward a Pro-Metastatic Phenotype Through MET,” Nature Medicine 18, no. 6 (2012): 883–891.

Rights & permissions

2026 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.